MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2017 International Congress

    AAV-mediated human alpha synuclein overexpression in the locus coeruleus (LC) leads to a neuronal loss in the nucleus ambiguus of mouse.

    B. Lee, M. Henrich, W.-H. Chiu, L. Matschke (Marburg, Germany)

    Objective: To investigate the impact and temporal aspects of the neuronal loss in the LC neurons induced by alpha-synucleinopathy Background: In the Braak staging model…
  • 2017 International Congress

    Efficacy of Tozadenant in Animal Models of Non-Motor Symptoms of Parkinson’s Disease

    C. Kostrub, C. Kenney, C. Riemer, E. Prinssen, A. Flohr, J.-L. Moreau (Ardsley, NY, USA)

    Objective: Investigate the potential of tozadenant (TOZ) to alleviate the non-motor symptoms of Parkinson's disease using multiple animal models. Background: TOZ is an oral, selective…
  • 2017 International Congress

    Long-term Effects of Subthalamic Nucleus Deep Brain Stimulation on Quality of Life, Non-motor and Motor Symptoms

    H. Dafsari, J. Petry-Schmelzer, M. Strack, L. Stalinski, V. Visser-Vandewalle, A. Rizos, M. Silverdale, K. Ashkan, M. Samuel, J. Evans, A. Antonini, P. Martinez-Martin, K. Ray Chaudhuri, L. Timmermann (Cologne, Germany)

    Objective: To study the long-term effects of bilateral subthalamic deep brain stimulation (STN-DBS) on Quality of Life (QoL), motor, non-motor symptoms (NMS) in patients with…
  • 2017 International Congress

    Lower education level is associated with greater disability from pain in Parkinson’s disease patients

    A.Q. Rana, A.R. Qureshi, Z. Sarfaraz, R. Rana (Toronto, ON, Canada)

    Objective: The objective of the current study is to explore whether a relationship between the level of educational attainment and degree of disability from pain…
  • 2017 International Congress

    [11C]PK11195 PET in Alzheimer’s disease and progressive supranuclear palsy: the NIMROD study

    P. Vazquez Rodriguez, J. Rowe, J. O'Brien, F. Aigbirhio, T. Fryer, L. Su, E. Mak, A. Surendranathan, R. Borchert, S. Jones, R. Arnold, R. Bevan-Jones, L. Passamonti, Y. Hong (Cambridge, United Kingdom)

    Objective: Here we test whether the intensity and regional distribution of neuro-inflammation differs between Alzheimer's disease (AD), Progressive Supranuclear Palsy (PSP) and controls; and whether neuro-inflammation…
  • 2017 International Congress

    Gait and Cognition in Progressive Supranuclear Palsy: A Significant Association

    K. Chatterjee, B. Mondal, S. Choudhury, H. Kumar (Kolkata, India)

    Objective: In this study we explored the association between gait parameters and cognitive function of PSP. Background: Gait and cognition are interrelated in patients with…
  • 2017 International Congress

    Extrapyramidal involvement in amyotrophic lateral sclerosis: results of a prospective population-based study

    M. Rizzone, F. Dematteis, A. Chiò, S. Cammarosano, C. Artusi, M. Pagani, F. Nobili, A. Cistaro, M. Balma, E. Montanaro, B. Iazzolino, A. Canosa, L. Lopiano, A. Calvo (Torino, Italy)

    Objective: To assess frequency, clinical characteristics and functional neuroimaging correlates of parkinsonian signs in a population-based series of new-diagnosed amyotrophic lateral sclerosis (ALS) patients. Background:…
  • 2017 International Congress

    Metabolomics study in a group of Parkinson’s disease patients from Northern India

    G.N. Babu, M. Gupta, V.K. Paliwal, S. Singh, R. Roy (Lucknow, India)

    Objective: To do (1) H NMR study in a group of Parkinson’s disease patients, disease controls, viz. multiple system atrophy (MSA) and progressive supra nuclear…
  • 2017 International Congress

    Alien Limb Syndrome Induced by a Dopamine Agonist in a Patient with Parkinsonism and Agenesis of the Corpus Callosum

    M. Krause, J. Shou, S. Joy, D. Torres-Russotto (Omaha, NE, USA)

    Objective: To examine the case of a patient with parkinsonism and agenesis of the corpus callosum whose alien limb phenomenology ceased after withdrawal from ropinirole.…
  • 2017 International Congress

    A case of Dementia with Lewy Bodies Co-Occuring with Multiple Sclerosis

    A. Hannoun, E. DeGrush, K. Smith, T. Kao, A. Deb (Worcester, MA, USA)

    Objective: To describe a unique case of Dementia with Lewy bodies (DLB) co-occurrence with Multiple Sclerosis (MS) Background: Various movement disorders have been described in…
  • « Previous Page
  • 1
  • …
  • 138
  • 139
  • 140
  • 141
  • 142
  • …
  • 155
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
    • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Life expectancy with and without Parkinson’s disease in the general population
    • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
    • An atypical and interesting feature of Parkinson´s disease
    • Effect of marijuana on Essential Tremor: A case report
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley